NUADA, LDA

Their core work

NUADA is a Portuguese deep-tech SME that develops wearable hand exoskeleton technology — specifically a robotic glove that augments or restores hand grip strength. Their product targets two distinct markets: workers in physically demanding industrial environments where repetitive hand strain causes injury, and people with reduced hand function due to neurological or musculoskeletal conditions. They progressed through the EU's competitive SME Instrument program, first validating the concept in 2017 and then executing a full commercial development phase through 2022, indicating a product-driven company rather than a research lab. Their core competence is translating biomechanics and ergonomics research into a wearable hardware product.

What they specialise in

How they've shifted over time

NUADA's H2020 trajectory follows a textbook SME Instrument commercialization path: the 2017 Phase 1 project was a short feasibility and business case validation with no published technical keywords, suggesting the technology concept was still being defined. By 2019, the Phase 2 project carried a fully articulated technical profile — exoskeleton, glove, hand strength, industrial application, ergonomics — showing the company had locked in both its product and its target market segments. The evolution is not a change of direction but a sharpening of focus: from concept to commercial-ready product with defined industrial and ergonomic applications.

NUADA is on a product commercialization trajectory — having completed a €1.7M EU-backed development phase, the likely next step is market entry and scaling, making them an interesting partner for industrial safety integrators, rehabilitation device distributors, or manufacturing automation suppliers.

How they like to work

NUADA operates exclusively as a solo project leader — both H2020 grants were won through the SME Instrument, a program specifically designed for single innovative companies rather than research consortia. This means they have no recorded consortium partners and have not co-developed technology with external research or industrial partners within the H2020 system. For future collaborations, expect them to engage as a product provider or technology licensor rather than as a consortium team player seeking joint R&D.

NUADA's H2020 record shows zero consortium partners and zero countries collaborated with — a direct consequence of the solo-applicant SME Instrument structure they used for both grants. Their collaboration network, if any, exists outside the formal EU project framework.

What sets them apart

NUADA is one of a very small number of European SMEs that have successfully taken a hand exoskeleton product through the full EU SME Instrument pipeline — from Phase 1 feasibility to Phase 2 commercial development — which signals both technical credibility and business viability validated by EU evaluators. Their dual positioning across industrial ergonomics and physical rehabilitation gives them access to two large, growing markets rather than a single niche. For a consortium builder, they bring a finished or near-finished hardware product with proven EU funding track record, which is rare among deep-tech SMEs at this stage.

Highlights from their portfolio

• NUADA
  The 2019–2022 SME Phase 2 project secured €1.72M — one of the larger individual SME Instrument grants — to bring the hand exoskeleton glove from prototype to commercial product, covering industrial and ergonomic applications.
• NUADA
  The 2017 SME Phase 1 project marks the formal EU validation of the concept, demonstrating that NUADA passed the competitive EIC feasibility review early and built its full development case on that foundation.